Lonaprisan
Overview[edit | edit source]
Lonaprisan is a synthetic steroidal selective progesterone receptor modulator (SPRM) that has been investigated for its potential use in the treatment of breast cancer and other hormone-dependent conditions. It is known for its ability to modulate the activity of the progesterone receptor, which plays a crucial role in the regulation of the menstrual cycle and pregnancy.
Chemical Structure[edit | edit source]
Lonaprisan is characterized by its unique chemical structure, which allows it to bind selectively to the progesterone receptor. The skeletal formula of Lonaprisan is depicted in the image to the right, illustrating its complex arrangement of carbon, hydrogen, and other atoms.
Mechanism of Action[edit | edit source]
Lonaprisan functions by binding to the progesterone receptor and modulating its activity. Unlike progesterone, which is a natural hormone that activates the receptor, Lonaprisan can act as an antagonist, blocking the receptor's activity. This property makes it useful in conditions where progesterone's effects need to be inhibited, such as in certain types of breast cancer.
Clinical Applications[edit | edit source]
The primary area of research for Lonaprisan has been in the treatment of hormone-dependent breast cancer. By inhibiting the action of progesterone, Lonaprisan may help to slow the growth of cancer cells that rely on this hormone for proliferation. Additionally, its role as a selective modulator means it could potentially have fewer side effects compared to other treatments that completely block hormone activity.
Development and Research[edit | edit source]
Lonaprisan has undergone various stages of clinical trials to assess its efficacy and safety. While initial results have shown promise, further research is needed to fully understand its potential benefits and risks. The development of Lonaprisan is part of a broader effort to create targeted therapies that can more effectively treat hormone-dependent conditions with minimal side effects.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
